143 related articles for article (PubMed ID: 10424282)
1. Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis.
George DK; Ramm GA; Walker NI; Powell LW; Crawford DH
J Hepatol; 1999 Jul; 31(1):47-52. PubMed ID: 10424282
[TBL] [Abstract][Full Text] [Related]
2. Evidence for altered hepatic matrix degradation in genetic haemochromatosis.
George DK; Ramm GA; Powell LW; Fletcher LM; Walker NI; Cowley LL; Crawford DH
Gut; 1998 May; 42(5):715-20. PubMed ID: 9659170
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases -1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: comparison using ROC analysis.
Walsh KM; Timms P; Campbell S; MacSween RN; Morris AJ
Dig Dis Sci; 1999 Mar; 44(3):624-30. PubMed ID: 10080160
[TBL] [Abstract][Full Text] [Related]
4. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
Zhang BB; Cai WM; Weng HL; Hu ZR; Lu J; Zheng M; Liu RH
World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C.
Boeker KH; Haberkorn CI; Michels D; Flemming P; Manns MP; Lichtinghagen R
Clin Chim Acta; 2002 Feb; 316(1-2):71-81. PubMed ID: 11750276
[TBL] [Abstract][Full Text] [Related]
8. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease.
Santos VN; Leite-Mór MM; Kondo M; Martins JR; Nader H; Lanzoni VP; Parise ER
Braz J Med Biol Res; 2005 May; 38(5):747-53. PubMed ID: 15917956
[TBL] [Abstract][Full Text] [Related]
9. Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?
Tsutsumi M; Takase S; Urashima S; Ueshima Y; Kawahara H; Takada A
Alcohol Clin Exp Res; 1996 Dec; 20(9):1512-7. PubMed ID: 8986196
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease.
Murawaki Y; Yamada S; Ikuta Y; Kawasaki H
J Hepatol; 1999 Jun; 30(6):1090-8. PubMed ID: 10406188
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
Wang T; Wang B; Liu X
Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):185-90. PubMed ID: 11244978
[TBL] [Abstract][Full Text] [Related]
12. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response.
Kasahara A; Hayashi N; Mochizuki K; Oshita M; Katayama K; Kato M; Masuzawa M; Yoshihara H; Naito M; Miyamoto T; Inoue A; Asai A; Hijioka T; Fusamoto H; Kamada T
J Hepatol; 1997 Mar; 26(3):574-83. PubMed ID: 9075665
[TBL] [Abstract][Full Text] [Related]
13. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology.
Murawaki Y; Ikuta Y; Koda M; Kawasaki H
Hepatology; 1994 Oct; 20(4 Pt 1):780-7. PubMed ID: 7927217
[TBL] [Abstract][Full Text] [Related]
14. [The relationship of serum metalloproteinase with the severity of liver fibrosis and inflammation].
Yin SS; Li XM; Wang BE; Wang TL; Jia JD; Qian LX
Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):666-8. PubMed ID: 15623375
[TBL] [Abstract][Full Text] [Related]
15. Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid.
Leroy V; Monier F; Bottari S; Trocme C; Sturm N; Hilleret MN; Morel F; Zarski JP
Am J Gastroenterol; 2004 Feb; 99(2):271-9. PubMed ID: 15046217
[TBL] [Abstract][Full Text] [Related]
16. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Fontana RJ; Goodman ZD; Dienstag JL; Bonkovsky HL; Naishadham D; Sterling RK; Su GL; Ghosh M; Wright EC;
Hepatology; 2008 Mar; 47(3):789-98. PubMed ID: 18175357
[TBL] [Abstract][Full Text] [Related]
17. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
[TBL] [Abstract][Full Text] [Related]
18. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
Pereira TN; Lewindon PJ; Smith JL; Murphy TL; Lincoln DJ; Shepherd RW; Ramm GA
J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of measurement of PIIIP, laminin P1, type IV-C and 7S in patients with chronic liver diseases--with special reference to histological findings].
Sato S
Nihon Shokakibyo Gakkai Zasshi; 1992 Sep; 89(9):2007-15. PubMed ID: 1404988
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study.
El-Mezayen HA; Habib S; Marzok HF; Saad MH
Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):378-85. PubMed ID: 25874509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
